Skip to Content

Lower Cognitive and Psychiatric Adverse Events During Adjunctive Cenobamate

Cenobamate may be a suitable treatment option for patients who experience cognitive or psychiatric treatment-emergent adverse events with their current ASMs. In this MEDtalk, William E. Rosenfeld, MD, part-time consultant and advisor at SK Life Science, USA, presents two studies of cenobamate treatment.

William E. Rosenfeld

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top